Mednet Logo
HomeMedical Oncology
Medical Oncology

Medical Oncology

Physician insights on cancer treatment protocols, immunotherapy, targeted therapies, and clinical trial updates.

Recent Discussions

Is it time to start incorporating involved site irradiation for all lymphomas?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Johns Hopkins University School of Medicine

Involved site radiation is becoming the new standard therapy for lymphomas and the goal is to incorporate the ISRT concept broadly. ISRT evolved to update field design guidelines to take into account 3D imaging rather than base field design on bony anatomy which is the way we designed fields in the ...

Can you observe low grade follicular lymphoma if the involved node(s) have been surgically removed?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Hospital of the University of Pennsylvania

There are certainly circumstances where observation for limited stage, low grade follicular lymphoma is warranted. I would not rely on surgical resection alone for cure however. Occasionally surgery can be curative in Stage I extranodal MALT lymphoma.

Is IMRT preferred over 3D conformal RT for lymphoma of the head and neck?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

If, based on the location of the node, we can spare the parotid gland more then we would do. The dose response curve for parotid salivary function is sigmoidal and not an all or none phenomenon, which is to say that the mean dose of 15Gy better than 25Gy which is better than 35Gy. As these patients ...

In treating with total body irradiation, how should the lung blocks be drawn and what dose should the lung receive?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northwestern University

I draw lung blocks 1 cm. insde the edge of peripheral lung including apex of the lung . The doses are usally 5% less than the prscribed doses to central axis . The typical TBI schedule as a conditioning regimen for BMT is 150 cGy BID for 1200 cGy . Bharat

What is the treatment volume for primary breast lymphoma?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

This is a rare presentation for DLBCL. In most instances tumor fairly small and lumpectomy can be performed and usually has been before dx is established. Post chemo I usually rx whole breast to 30gy. One could argue against RT theoretically if lumpectomy with neg margins has been performed but it i...

When do you recommend consolidative XRT for patients with advanced stage (III-IV) DLBCL who achieve CR to chemoimmunotherapy?

8
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The cornerstone of therapy for advanced DLBCL is chemoimmunotherapy (R-CHOP). Efforts to improve upon this with systemic therapy have been largely unsuccessful (dose-dense chemotherapy, maintenance R, more intensive chemotherapy, high-dose chemotherapy and autologous SCT, etc.). There are increasing...

What is the role of radiation consolidation after chemotherapy for residual splenic involvement in follicular lymphoma?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northwestern University

Recommend 3000 cGy in 15 fractions

In which patients with early-stage favorable Hodgkin's lymphoma, if any, would you consider omitting consolidation RT after ABVD chemotherapy?

5
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The GHSG HD16 randomized trial was recently reported at ASH (Abstract 925). Patients with early-stage, favorable HL (per GHSG criteria) were randomized to standard treatment (ABVD X 2 followed by 20 Gy of RT) or a PET-directed approach. If PET negative after 2 cycles (defined as Deauville 1-2), then...

In Stage I-II primary mediastinal B-cell lymphoma (PMBL), bulky or non-bulky, is post-chemotherapy radiotherapy still standard in patients with a complete response to CHOP-R chemotherapy?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

Primary mediastinal B-cell lymphoma (PMBCL) is a rare subtype of DLBCL. It is a clinicopathologic entity by WHO criteria (which makes it occasionally difficult to conclusively diagnose). The typical patient is young, female, with a large, anterior mediastinal mass. The optimal therapy for PMBCL is c...

Is there a role for consolidation radiation in a patient with stage I low grade follicular lymphoma treated with chemotherapy?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

First, while there is no "standard" treatment for stage I follicular lymphoma due to a scarcity of randomized studies, most North American and European guidelines indicate that the "preferred" treatment is radiation therapy. This is based on several single institution series demonstrating that radia...